Cannabis greatly reduces headache and migraine pain, says new study
Washington State researchers made headlines this week thanks to one of the first major US-based studies to research cannabis and its potential to alleviate headaches and migraines, published in the Journal of Pain.
“We were motivated to do this study because a substantial number of people say they use cannabis for headache and migraine, but surprisingly few studies had addressed the topic,” said study lead author Carrie Cuttler, an assistant professor of psychology at Washington State University.
Studying 1,300 patients who suffered from common headaches, Cutler and her team found that patients reduced their pain by nearly 50% after consuming cannabis.
Participants in the study used a wide-variety of products, ranging from concentrates to flower, and high-THC to CBD-dominant edibles. Researchers found few disparities between the handful of consumption methods, but concentrates were related to the largest reductions in headache and migraines.
One other interesting note is that “high-usage” resulted in no clear negative results.
“We did, however, find that cannabis was not associated with medication overuse headache, which is a common pitfall of more conventional treatments,” stated Cutler.
Medical cannabis importation and domestic hemp cultivation approved in Brazil
Anvisa, Brazil’s national health regulatory agency, approved regulations early Monday morning that would allow domestic health businesses to import medicinal cannabis products.
Under the proposal, interested entrepreneurs would have to first secure a handful of licenses falling under the importation, prescription, and sale of the plant.
The approval is another sign of Brazil’s culture shift clashing with far-right President Jair Bolsonaro, who has been staunch in his disdain for cannabis (and all drugs for that matter).
Nationwide survey suggests consumers want organic, eco-friendly products
CGS LTD., a large ancillary cannabis business focused on disrupting the hydroponics industry, recently released their findings of a nationwide survey that polled cannabis consumers in adult-use states.
The study was designed to better understand where consumers stand on environmental issues related to the plant; answering questions themed around pesticides, organic practices, and eco-friendly packaging.
Respondents clearly indicated they’re willing to pay more for organic, pesticide-free products, with 64% of the 600 respondents agreeing they’d pay a premium price for organic, eco-friendly products.
Other interesting findings include:
**(percent) = total population surveyed that favors products grown using the following methods
- grown free from chemical pesticides (92%),
- without chemical fertilizers (88%),
- hasn’t been irradiated for pathogens (85%),
- is grown in a low carbon footprint environment (82.5%), and
- cultivated in a manner that conserves water (86%)
“The research suggests that consumers are more sophisticated and discerning in their brand trust than was previously thought. We believe new approaches to cultivation and testing are needed to preserve trust in this new market. The more educated consumers become, the more they will demand products that are environmentally friendly and certifiably proven to be free of chemical toxins, pathogens and decontamination treatments,” stated Troy McCellan, CEO of Canivate.
Minnesota regulators expand MMJ program
Two new qualifying conditions, approved by Health Commissioner Jan Malcolm, are expected to soon be included in the state’s evolving medical cannabis program.
With the new addition of chronic pain and age-related macular degeneration (a severe eye-disease), Minnesota’s medical cannabis program now includes 16 qualifying conditions – and is expected to quickly blossom with the addition of chronic pain.
“The bottom line is that people suffering from these serious conditions may be helped by participating in the program, and we felt it was important to give them the opportunity to seek that relief,” stated Malcolm
With the new Health Commissioner supportive of program expansion, and a standing Governor eager to roll-out an adult-use market, Minnesota is likely to be the next Midwestern state to end prohibition.